All News about 4D Molecular Therapeutics Inc
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for 4D Molecular Therapeutics
April 13, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
![](/next-assets/images/schema-image-default.png)
Expert Ratings for 4D Molecular Therapeutics
March 16, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for 4D Molecular Therapeutics
January 30, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/27/fdmt.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Thursday's Intraday Session
April 27, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/27/netgear_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/27/image20.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
![](https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png)
![](https://ml.globenewswire.com/media/48db3c0d-41d9-436f-9867-c5d6c586c7a4/small/4dmt-png.png)
![](https://investorplace.com/wp-content/uploads/2022/06/millionaire-stocks-to-buy-1600.png)
![](https://ml.globenewswire.com/media/48db3c0d-41d9-436f-9867-c5d6c586c7a4/small/4dmt-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/02/23/fdmt_logo_light__1394f4f7f29565c6b00e508c771cc6f9.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/48db3c0d-41d9-436f-9867-c5d6c586c7a4/small/4dmt-png.png)
![](https://ml.globenewswire.com/media/48db3c0d-41d9-436f-9867-c5d6c586c7a4/small/4dmt-png.png)
![](https://ml.globenewswire.com/media/48db3c0d-41d9-436f-9867-c5d6c586c7a4/small/4dmt-png.png)
![](https://ml.globenewswire.com/media/48db3c0d-41d9-436f-9867-c5d6c586c7a4/small/4dmt-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/01/30/fdmt_logo_light__1394f4f7f29565c6b00e508c771cc6f9.png?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023
January 30, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/48db3c0d-41d9-436f-9867-c5d6c586c7a4/small/4dmt-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23618.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.